The US Food and Drug Administration and industry worked hard to clear their desks in the days leading up to Thanksgiving, issuing a bevy of drug development announcements. Here are just a few of the week's most notable events:
Sickle cell patients are likely to be thankful for the FDA's review speed this Thanksgiving, as the agency's 25 November...





